Charles Taerk discusses NanoSphere Health Sciences

- January 17th, 2019

Faircourt Asset Management President and CEO Charles Taerk discussed NanoSphere Health Sciences (CSE:NSHS) with BNN Bloomberg. Nanosphere is a nano-biotechnology company focused on providing next generation delivery of nutritive elements and medication. Taerk talked about how Nanosphere’s technology breaks down cannabis oils, which are very thick and not easily digestible, to increase their bioavailability and ensure that patients receive fast relief for their symptoms.

Faircourt Asset Management President and CEO Charles Taerk discussed NanoSphere Health Sciences (CSE:NSHS) with BNN Bloomberg in an interview with the publication. Nanosphere is a nano-biotechnology company focused on providing next generation delivery of nutritive elements and medication. Taerk talked about how Nanosphere’s technology breaks down cannabis oils, which are very thick and not easily digestible. The technology helps increase their bioavailability and ensure that patients receive fast relief for their symptoms.

While Taerk believes that Nanosphere has hit some important milestones and breakthroughs with their technology, he believes the company has more work to do. His view is that Nanosphere’s next step will be to develop an odorless, tasteless and colourless formulation that can be applied to beverages. He pointed out that most people want to buy a drink that is like every other on the market, while still accessing the benefits associated with cannabis.

To watch the full interview, click here.

Click here to connect with NanoSphere Health Sciences (CSE:NSHS) for an Investor Presentation. 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select All
Select None

Leave a Reply

Your email address will not be published. Required fields are marked *